Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minidose LSD for chronic cluster headache
NL-OMON57258Phase 2Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lysergide in Cluster Headache (CH), sponsored by Radboud University Medical Center. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
Lysergide
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NL-OMON57258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57258.